Literature DB >> 23970647

Recurrent giant molluscum contagiosum immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy in an HIV-infected man.

Paul K Drain1, Anisa Mosam, Lilishia Gounder, Bernadett Gosnell, Thandekile Manzini, Mahomed-Yunus S Moosa.   

Abstract

We describe an HIV-infected South African man who experienced two distinct episodes of disseminated giant molluscum contagiosum immune reconstitution inflammatory syndrome (IRIS) over a six-year period. The first episode of molluscum contagiosum IRIS occurred with rapid virologic suppression following antiretroviral therapy initiation. The second episode occurred during a rapid increase in CD4 cells following stable viral suppression with second-line antiretroviral therapy. His molluscum contagiosum lesions then completely resolved during a reduction in CD4 count, despite maintaining virologic suppression. Nearly one year after the resolution of his giant molluscum contagiosum IRIS lesions, he maintains an undetectable viral load, but his level of immune deficiency has not improved. In the absence of well-controlled therapeutic trials, molluscum contagiosum IRIS presents important management challenges.

Entities:  

Keywords:  HIV/AIDS; IRIS; Molluscum contagiosum; South Africa; antiretroviral therapy; immune reconstitution inflammatory syndrome

Mesh:

Year:  2013        PMID: 23970647      PMCID: PMC4000481          DOI: 10.1177/0956462413497702

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  19 in total

1.  Molluscum contagiosum in an immune reconstituted AIDS patient.

Authors:  T Albini; N Rao
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients.

Authors:  J J Schwartz; P L Myskowski
Journal:  J Am Acad Dermatol       Date:  1992-10       Impact factor: 11.527

Review 3.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

4.  An inflammatory reaction surrounding molluscum contagiosum as possible manifestation of immune reconstitution inflammatory syndrome in HIV infection.

Authors:  Vânia Oliveira de Carvalho; Cristina Rodrigues Cruz; Lúcia Noronha; Kerstin Taniguchi Abagge; Hermênio Cavalcante Lima
Journal:  Pediatr Dermatol       Date:  2010-11-16       Impact factor: 1.588

5.  Resolution of severe molluscum contagiosum on effective antiretroviral therapy.

Authors:  C K Horn; G R Scott; E C Benton
Journal:  Br J Dermatol       Date:  1998-04       Impact factor: 9.302

6.  Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine.

Authors:  M A Hurni; L Böhlen; H Furrer; L R Braathen
Journal:  AIDS       Date:  1997-11-15       Impact factor: 4.177

7.  Resolution of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir.

Authors:  C B Hicks; S A Myers; J Giner
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

8.  Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum.

Authors:  U R Hengge; S Esser; T Schultewolter; C Behrendt; T Meyer; E Stockfleth; M Goos
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

9.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Fehmida Visnegarwala; Jorge Darcourt; Edward A Graviss; Thomas P Giordano; A Clinton White; Richard J Hamill
Journal:  AIDS       Date:  2005-03-04       Impact factor: 4.177

Review 10.  The epidemiology of Molluscum contagiosum in HIV-seropositive patients: a unique entity or insignificant finding?

Authors:  I Gur
Journal:  Int J STD AIDS       Date:  2008-08       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.